• URGENT FOR SHAREHOLDERS –

In terms of SEBI Circular SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/37 dated March 16, 2023, it hereby informed to all holders of physical securities of Brawn Biotech Limited to furnish their PAN, Nomination, Contact details (Email id and Mobile No.), Bank A/c Details and Specimen Signatures for their corresponding folio numbers.

IMPORTANT: In the event of non-receipt of the above details, concerned shares shall be frozen from October 01, 2023


 

  • URGENT FOR PROMOTER AND PROMOTERS’ GROUP-

UPDATE KYC AND CONVERT PHYSICAL SHARES INTO DEMAT MODE

The Shareholders who are holding shares in Physical form are requested to  update their KYC and also requested to convert their physical share Certificates in to dematerialized form ( electronic Form).Further pursuant to SEBI Circular No. SEBI/Cir/ISD/3/2011 dated June 17, 2011 in order to promote dematerialization of securities, it is mandatory for the Company to achieve 100% of promoter’s and promoter group’s shareholding in dematerialized form, thereby they are requested to convert their holdings in dematerialized form on priority basis.

Read More

We Distribute Health Care Products in Domestic and International Markets

Our Pharmaceutical Formulations cover all major product segments like Antibacterials, Cardiovasculars, Antidiabetics, Analgesics, Gastrointestinals, Antifungals, Skin Care, Antipsychotics, Antiasthmatics, Antacids, Antimalarials, and Nutritionals.
Read More

Brawn Biotech

BRAWN, with its inception barely 39 years back(1986) has today evolved into a fully integrated, healthcare group, marking its presence in India and dotting various major markets across the globe. BRAWN is proud to possess product registration with major health and govt. institutions throughout India and in many other countries worldwide. Headed and represented by a team of skilled industry experts with impressive educational backgrounds and broad experience, BRAWN continues to spread its wings in expansion in the domestic as well as in the international markets with a vision beyond the existing horizon to stand among the leading Indian HealthCare product distribution Companies.

Investors

Investors can email their queries to solution@brawnbiotech.com